CLINICAL_TRIALS
trial_result
· 2010-01-08
Clinical Trial Update: Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation [Phase 2]
Summary
Phase 2 trial evaluating K201 Injection for restoration of sinus rhythm in atrial fibrillation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sequel Pharmaceuticals, Inc | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED